TD Private Client Wealth’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Sell
5,098
-92
-2% -$20.1K 0.03% 335
2025
Q1
$1.16M Buy
5,190
+648
+14% +$145K 0.03% 316
2024
Q4
$1.49M Buy
4,542
+305
+7% +$99.9K 0.04% 281
2024
Q3
$1.27M Sell
4,237
-137
-3% -$41.1K 0.04% 329
2024
Q2
$1.44M Buy
4,374
+790
+22% +$260K 0.05% 295
2024
Q1
$1.42M Sell
3,584
-64
-2% -$25.3K 0.05% 297
2023
Q4
$1.28M Sell
3,648
-40
-1% -$14.1K 0.05% 300
2023
Q3
$1.38M Sell
3,688
-202
-5% -$75.8K 0.06% 269
2023
Q2
$1.49M Sell
3,890
-235
-6% -$89.9K 0.06% 269
2023
Q1
$1.43M Sell
4,125
-46
-1% -$15.9K 0.06% 272
2022
Q4
$982K Buy
4,171
+118
+3% +$27.8K 0.05% 326
2022
Q3
$997K Sell
4,053
-120
-3% -$29.5K 0.05% 311
2022
Q2
$1.26M Sell
4,173
-643
-13% -$194K 0.06% 283
2022
Q1
$1.98M Sell
4,816
-328
-6% -$135K 0.08% 238
2021
Q4
$2.41M Buy
5,144
+295
+6% +$138K 0.1% 206
2021
Q3
$2.06M Sell
4,849
-575
-11% -$244K 0.09% 228
2021
Q2
$1.95M Sell
5,424
-385
-7% -$138K 0.08% 241
2021
Q1
$1.64M Buy
5,809
+484
+9% +$136K 0.08% 259
2020
Q4
$1.51M Buy
5,325
+280
+6% +$79.3K 0.08% 255
2020
Q3
$1.39M Buy
5,045
+604
+14% +$166K 0.08% 247
2020
Q2
$1.01M Buy
4,441
+1,465
+49% +$333K 0.06% 279
2020
Q1
$453K Buy
2,976
+202
+7% +$30.8K 0.03% 333
2019
Q4
$417K Buy
+2,774
New +$417K 0.03% 373